All In MedTech

FDA Clearance Tracker · P130006-S073

GORE VIABAHN Endoprosthesis product family abd GORE VIABAHN Endoprosthesis with Heparin Bioactive Surface product family

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Feb 28, 2020 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Feb 28, 2020

Approved

Time to decision

178 days

Received Sep 3, 2019. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P130006-S073
Device name
GORE VIABAHN Endoprosthesis product family abd GORE VIABAHN Endoprosthesis with Heparin Bioactive Surface product family
Applicant location
Flagstaff, AZ
Received
Sep 3, 2019
Decided
Feb 28, 2020
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Location Change - Manufacturer/Sterilizer/Packager/Supplier
Original approval
P130006

Device type

Device class
Class III

Every decision under product code PFV

FDA's approval statement

As written in FDA's record.

Approval of a new ethylene oxide sterilization cycle to pe performed at a new sterilization site (Sterigenics US, LLC located at 4900 Gifford Ave. Los Angeles, CA).

Source documents

Other decisions for W. L. Gore & Associates, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.